Health
Moderna COVID-19 vaccine successful against emerging variants – European Pharmaceutical Review
Results from in vitro neutralisation studies have shown that Moderna’s COVID-19 vaccine is effective against emerging strains of SARS-CoV-2.
Posted: 27 January 2021 | Victoria Rees (European Pharmaceutical Review) | No comments yet
Results from in vitro neutralisation studies have shown that Moderna’s COVID-19 vaccine is effective against emerging strains of SARS-CoV-2.
Moderna has announced results from in vitro neutralisation studies of sera from individuals vaccinated with the company’s COVID-19 vaccine showing activity against emerging strains of SARS-CoV-2.
According to the company, vaccination with the Moderna COVID-19 vaccine…
-
Business16 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
General22 hours agoMichael Beatty, veteran current affairs journalist and animal welfare advocate, dies aged 76
-
Noosa News15 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
Noosa News12 hours agoTips to improve engagement – Proctor